Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 15.61 Billion | USD 29.93 Billion | 7.5% | 2023 |
The global Gynecological Drugs Market size was worth around USD 15.61 billion in 2023 and is predicted to grow to around USD 29.93 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.5% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Gynecological Drugs Market on a global and regional level.
The treatment of gynecological ailments is purely drug-dependent. In recent times, the gynecological pharmacology field has bloomed like never before. Furthermore, the availability of the ultraprecise advanced gynecological investigation, direct monitoring facility, and various medical options for the treatment of gynecological ailments is increasing. With the establishment of down and up-regulation policies, the different treatment options, such as hypothalamus and pituitary, have now become a very easy tool for gynecologists to treat hormonal disorders. These gynecological disorders include conditions affecting ovaries, uterus, and their appendages.
There are various factors expected to support the growth of the global gynecological drugs market in the future, such as the increasing prevalence of gynecological diseases. Changing lifestyle of females across the globe has eventually put them at a higher risk of suffering from various types of gynecological disorders, which, in turn, is fuelling the global gynecological drugs market. The awareness about one’s well-being and health has increased, which has led to the rise for better gynecological treatments and the manufacturers have innovated newer drugs for treating gynecological disorders with fewer side-effects and better efficacy. These are also projected to fuel this global market.
The study provides a decisive view of the gynecological drugs market by segmenting the market based on therapeutics, indication, distribution channel, and region. All the segments have been analyzed based on present and future trends in the market that is estimated from 2024 to 2032.
Based on therapeutics, the market is segmented into hormonal therapy and non-hormonal therapy. Non-hormonal therapy is expected to hold the major market share over the estimated timeline.
Based on the indication, the market is segmented into gynecology infections, gynecology cancers, endometriosis, polycystic ovary syndrome, female infertility, menopausal disorder, contraception (birth control), and others. Polycystic ovary syndrome is expected to grow significantly over the forecast timeline.
Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies held the major share of the global market in 2023.
Report Attributes | Report Details |
---|---|
Report Name | Gynecological Drugs Market |
Market Size in 2023 | USD 15.61 Billion |
Market Forecast in 2032 | USD 29.93 Billion |
Growth Rate | CAGR of 7.5% |
Number of Pages | 110 |
Key Companies Covered | Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others |
Segments Covered | By therapeutics, By indication, By distribution channel and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.
North America is expected to lead the global gynecological drugs market over the forecast timeline, due to the high expenditure on women’s health, substantial research and development activities witnessed in the gynecology domain. Europe is predicted to trail behind North America in terms of growth and be the second largest gynecological drugs market in the years ahead. Asia Pacific is likely to record a high CAGR over the forecast timeframe, owing to the introduction of new and approved gynecological drugs, the presence of strong healthcare infrastructure, increased affordability of the gynecological drugs, and technological advancements.
Some key players of the gynecological drugs market are:
Global Gynecological Drugs Market: Therapeutics Analysis
Global Gynecological Drugs Market: Indication Type Analysis
Global Gynecological Drugs Market: Distribution Channel Analysis
Global Gynecological Drugs Market: Regional Analysis
FrequentlyAsked Questions
Gynecological drugs are medications used to treat various conditions related to women's reproductive health. These drugs can address issues ranging from hormonal imbalances and menstrual disorders to fertility challenges and menopause symptoms.
According to study, the Gynecological Drugs Market size was worth around USD 15.61 billion in 2023 and is predicted to grow to around USD 29.93 billion by 2032.
The CAGR value of Gynecological Drugs Market is expected to be around 7.5% during 2024-2032.
North America has been leading the Gynecological Drugs Market and is anticipated to continue on the dominant position in the years to come.
The Gynecological Drugs Market is led by players like Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed